Pulse Biosciences, Inc. (PLSE)
NASDAQ: PLSE · Real-Time Price · USD
13.27
0.00 (0.00%)
At close: Dec 5, 2025, 4:00 PM EST
13.31
+0.04 (0.30%)
After-hours: Dec 5, 2025, 5:27 PM EST
Pulse Biosciences Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Revenue | 0.09 | - | - | 0.7 | 1.42 | - | |
| Revenue Growth (YoY) | - | - | - | -50.63% | - | - | |
| Cost of Revenue | 0.28 | - | - | 11.94 | 1.97 | - | |
| Gross Profit | -0.19 | - | - | -11.24 | -0.55 | - | |
| Selling, General & Admin | 34.3 | 23.92 | 15.78 | 25.97 | 33.82 | 23.52 | |
| Research & Development | 44.46 | 32.34 | 27.8 | 20.84 | 28.64 | 26.44 | |
| Operating Expenses | 78.75 | 56.26 | 43.57 | 46.81 | 62.46 | 49.97 | |
| Operating Income | -78.95 | -56.26 | -43.57 | -58.06 | -63.01 | -49.97 | |
| Interest Expense | - | - | -1.1 | -0.9 | -0.7 | - | |
| Interest & Investment Income | 4.25 | 2.67 | 2.46 | 0.64 | 0.05 | 0.23 | |
| Other Non Operating Income (Expenses) | -0.04 | - | - | - | - | - | |
| EBT Excluding Unusual Items | -74.73 | -53.59 | -42.21 | -58.32 | -63.66 | -49.73 | |
| Gain (Loss) on Sale of Assets | - | - | - | -0.19 | - | -0.12 | |
| Pretax Income | -74.73 | -53.59 | -42.21 | -58.51 | -63.66 | -49.85 | |
| Net Income | -74.73 | -53.59 | -42.21 | -58.51 | -63.66 | -49.85 | |
| Net Income to Common | -74.73 | -53.59 | -42.21 | -58.51 | -63.66 | -49.85 | |
| Shares Outstanding (Basic) | 66 | 58 | 50 | 34 | 28 | 23 | |
| Shares Outstanding (Diluted) | 66 | 58 | 50 | 34 | 28 | 23 | |
| Shares Change (YoY) | 15.43% | 17.41% | 46.56% | 21.35% | 20.29% | 12.06% | |
| EPS (Basic) | -1.13 | -0.92 | -0.85 | -1.72 | -2.28 | -2.14 | |
| EPS (Diluted) | -1.13 | -0.92 | -0.85 | -1.72 | -2.28 | -2.14 | |
| Free Cash Flow | -48.77 | -36.47 | -33.16 | -47.41 | -54.53 | -35.81 | |
| Free Cash Flow Per Share | -0.74 | -0.62 | -0.67 | -1.40 | -1.95 | -1.54 | |
| Gross Margin | -224.42% | - | - | - | -38.79% | - | |
| Operating Margin | -91798.84% | - | - | -8293.86% | -4443.87% | - | |
| Profit Margin | -86898.84% | - | - | -8357.86% | -4489.42% | - | |
| Free Cash Flow Margin | -56713.95% | - | - | -6773.43% | -3845.84% | - | |
| EBITDA | -77.85 | -55.08 | -42.37 | -56.7 | -61.87 | -48.87 | |
| D&A For EBITDA | 1.1 | 1.18 | 1.21 | 1.36 | 1.15 | 1.1 | |
| EBIT | -78.95 | -56.26 | -43.57 | -58.06 | -63.01 | -49.97 | |
| Revenue as Reported | - | - | - | 0.7 | 1.42 | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.